Mike Arnold
AUTHOR

Mike Arnold

Tap the gear icon above to manage new release emails.
Mike Arnold had a career as what passed as a "high-profile" criminal defense attorney in Oregon and then turned cannabis and psychedelics entrepreneur. He is also the co-inventor of the of the world’s first psilocybin nasal spray and founder of Silo Wellness (OTC:SILFF) (CSE:SILO).

Mike is experienced in jury trials & complex criminal & civil litigation involving multiple parties & witnesses, voluminous discovery, expert witnesses, & high stakes. He was managing partner of Arnold Law for 10 years & was the chief trial lawyer of the firm until he departed in June 2017.

Mike is also the author of "Finishing Machine,” a book about a client accused of murdering an unarmed man (a must read for anyone wishing to get a firsthand look at courthouse politics).

He also has a steady presence in national media including a CBS 48 Hours episode entitled “Trail of Tears” & his high-profile public response to the Malheur Wildlife Refuge Occupation through his representation of Ammon Bundy. Mike gained notoriety as an attorney when he stood on the courthouse steps as Ammon Bundy's attorney & told the remaining occupiers of the Malheur Wildlife Refuge to "please stand down." In the aftermath of the standoff he was credited with assisting in negotiating a peaceful resolution for the remaining four protester holdouts.

----
As stated in the Register-Guard : “Arnold says it’s rugby, which can get pretty rough, that ‘fits in perfectly with (his) personality.’ He’s quick to add that the attitude he brought to the pitch sometimes carries over to his law practice. ‘I have a tendency to put my head down & run into a wall if the cause is right.’
Read more Read less

Try Audible membership today. Start enjoying the benefits.

Try Audible for free with an audiobook of your choice.
Try Standard free
Auto-renews at AUD $8.99/mo after 30 days. Cancel anytime.

Most Popular

Product list
  • Finishing Machine cover art
    Preview

    $27.15 or free with 30-day trial